Annual CFO:
-$158.56M-$17.35M(-12.28%)Summary
- As of today, NAMS annual cash from operations is -$158.56 million, with the most recent change of -$17.35 million (-12.28%) on December 31, 2024.
- During the last 3 years, NAMS annual cash from operations has fallen by -$129.05 million (-437.29%).
- NAMS annual cash from operations is now -1586.77% below its all-time high of $10.66 million, reached on December 31, 2022.
Performance
NAMS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$32.77M+$4.90M(+13.01%)Summary
- As of today, NAMS quarterly cash from operations is -$32.77 million, with the most recent change of +$4.90 million (+13.01%) on September 30, 2025.
- Over the past year, NAMS quarterly cash from operations has dropped by -$20.27 million (-162.11%).
- NAMS quarterly cash from operations is now -5643.73% below its all-time high of $591.10 thousand, reached on December 31, 2021.
Performance
NAMS Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$144.39M-$20.27M(-16.33%)Summary
- As of today, NAMS TTM cash from operations is -$144.39 million, with the most recent change of -$20.27 million (-16.33%) on September 30, 2025.
- Over the past year, NAMS TTM cash from operations has dropped by -$23.31 million (-19.25%).
- NAMS TTM cash from operations is now -111742.76% below its all-time high of -$129.10 thousand, reached on June 30, 2022.
Performance
NAMS TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NAMS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -12.3% | -162.1% | -19.3% |
| 3Y3 Years | -437.3% | -10000.0% | -10000.0% |
| 5Y5 Years | -2059.4% | - | - |
NAMS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -1586.8% | at low | >-9999.0% | +40.0% | >-9999.0% | +8.9% |
| 5Y | 5-Year | -1586.8% | at low | -5643.7% | +40.0% | >-9999.0% | +8.9% |
| All-Time | All-Time | -1586.8% | at low | -5643.7% | +40.0% | >-9999.0% | +8.9% |
NAMS Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$32.77M(+13.0%) | -$144.39M(-16.3%) |
| Jun 2025 | - | -$37.67M(-3.3%) | -$124.12M(+11.6%) |
| Mar 2025 | - | -$36.47M(+2.7%) | -$140.43M(+11.4%) |
| Dec 2024 | -$158.56M(-12.3%) | -$37.48M(-199.8%) | -$158.56M(-31.0%) |
| Sep 2024 | - | -$12.50M(+76.8%) | -$121.08M(-11.5%) |
| Jun 2024 | - | -$53.98M(+1.1%) | -$108.58M(-98.9%) |
| Mar 2024 | - | -$54.60M(-71.4%) | -$54.60M(-69.2%) |
| Dec 2023 | -$141.22M(-1424.1%) | - | - |
| Mar 2023 | - | -$31.86M | -$32.28M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $10.66M(+136.1%) | - | - |
| Sep 2022 | - | -$239.90K(-39.0%) | -$215.10K(-66.6%) |
| Jun 2022 | - | -$172.60K(+56.2%) | -$129.10K(+60.8%) |
| Mar 2022 | - | -$393.70K(-166.6%) | -$329.60K(-138.2%) |
| Dec 2021 | -$29.51M(-301.9%) | $591.10K(+484.1%) | -$138.40K(+81.0%) |
| Sep 2021 | - | -$153.90K(+58.8%) | -$729.50K(-26.7%) |
| Jun 2021 | - | -$373.10K(-84.2%) | -$575.60K(-184.2%) |
| Mar 2021 | - | -$202.50K | -$202.50K |
| Dec 2020 | -$7.34M | - | - |
FAQ
- What is NewAmsterdam Pharma Company N.V. annual cash from operations?
- What is the all-time high annual cash from operations for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. annual cash from operations year-on-year change?
- What is NewAmsterdam Pharma Company N.V. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. quarterly cash from operations year-on-year change?
- What is NewAmsterdam Pharma Company N.V. TTM cash from operations?
- What is the all-time high TTM cash from operations for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. TTM cash from operations year-on-year change?
What is NewAmsterdam Pharma Company N.V. annual cash from operations?
The current annual cash from operations of NAMS is -$158.56M
What is the all-time high annual cash from operations for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high annual cash from operations is $10.66M
What is NewAmsterdam Pharma Company N.V. annual cash from operations year-on-year change?
Over the past year, NAMS annual cash from operations has changed by -$17.35M (-12.28%)
What is NewAmsterdam Pharma Company N.V. quarterly cash from operations?
The current quarterly cash from operations of NAMS is -$32.77M
What is the all-time high quarterly cash from operations for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high quarterly cash from operations is $591.10K
What is NewAmsterdam Pharma Company N.V. quarterly cash from operations year-on-year change?
Over the past year, NAMS quarterly cash from operations has changed by -$20.27M (-162.11%)
What is NewAmsterdam Pharma Company N.V. TTM cash from operations?
The current TTM cash from operations of NAMS is -$144.39M
What is the all-time high TTM cash from operations for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high TTM cash from operations is -$129.10K
What is NewAmsterdam Pharma Company N.V. TTM cash from operations year-on-year change?
Over the past year, NAMS TTM cash from operations has changed by -$23.31M (-19.25%)